心房颤动风险的罕见与常见遗传变异
该遗传关联与巢式病例对照研究基于英国生物银行403 990名欧洲裔参与者,发现6个基因的罕见pLOF变异与房颤相关,其中5个在外部队列复制;罕见pLOF变异合并高多基因风险评分时房颤风险显著增加,且与心肌病和心衰风险相关。
要点
- TTN、RPL3L、PKP2、CTNNA3、KDM5B和C10orf71的罕见pLOF变异与房颤相关。
- 罕见pLOF变异合并高PRS时房颤OR为7.08(95%CI 6.03-8.28)。
- 罕见pLOF变异携带者房颤前后心肌病风险均增加(HR 3.13和2.98)。
核心结论
- 罕见和常见遗传变异均与房颤风险增加相关,可能有助于未来遗传风险分层。
研究设计与样本
- 遗传关联与巢式病例对照研究,纳入英国生物银行403 990名欧洲裔参与者,中位年龄58岁,女性占54.1%,中位随访13.3年。
主要发现
- 随访期间24 447人诊断新发房颤。
- 6个基因(TTN、RPL3L、PKP2、CTNNA3、KDM5B、C10orf71)的罕见pLOF变异与房颤相关,其中5个在外部队列复制。
- 罕见pLOF变异合并高PRS时房颤OR为7.08(95%CI 6.03-8.28)。
- 高PRS携带者10年房颤风险在60岁以上女性为16%,男性为24%。
- 罕见pLOF变异与房颤前心肌病风险增加相关(HR 3.13;95%CI 2.24-4.36),房颤后亦相关(HR 2.98;95%CI 1.89-4.69)。
临床怎么用
- 可考虑结合罕见pLOF变异与PRS评估房颤遗传风险,高PRS携带者需关注房颤及心肌病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Atrial fibrillation (AF) has a substantial genetic component. The importance of polygenic risk is well established, while the contribution of rare variants to disease risk warrants characterization in large cohorts. OBJECTIVE: To identify rare predicted loss-of-function (pLOF) variants associated with AF and elucidate their role in risk of AF, cardiomyopathy (CM), and heart failure (HF) in combination with a polygenic risk score (PRS). DESIGN, SETTING, AND PARTICIPANTS: This was a genetic association and nested case-control study. The impact of rare pLOF variants was evaluated on the risk of incident AF. HF and CM were assessed in cause-specific Cox regressions. End of follow-up was July 1, 2022. Data were analyzed from January to October 2023. The UK Biobank enrolled 502 480 individuals aged 40 to 69 years at inclusion in the United Kingdom between March 13, 2006, and October 1, 2010. UK residents of European ancestry were included. Individuals with prior diagnosis of AF were excluded from analyses of incident AF. EXPOSURES: Rare pLOF variants and an AF PRS. MAIN OUTCOMES AND MEASURES: Risk of AF and incident HF or CM prior to and subsequent to AF diagnosis. RESULTS: A total of 403 990 individuals (218 489 [54.1%] female) with a median (IQR) age of 58 (51-63) years were included; 24 447 were diagnosed with incident AF over a median (IQR) follow-up period of 13.3 (12.4-14.0) years. Rare pLOF variants in 6 genes (TTN, RPL3L, PKP2, CTNNA3, KDM5B, and C10orf71) were associated with AF. Of these, TTN, RPL3L, PKP2, CTNNA3, and KDM5B replicated in an external cohort. Combined with high PRS, rare pLOF variants conferred an odds ratio of 7.08 (95% CI, 6.03-8.28) for AF. Carriers with high PRS also had a substantial 10-year risk of AF (16% in female individuals and 24% in male individuals older than 60 years). Rare pLOF variants were associated with increased risk of CM both prior to AF (hazard ratio [HR], 3.13; 95% CI, 2.24-4.36) and subsequent to AF (HR, 2.98; 95% CI, 1.89-4.69). CONCLUSIONS AND RELEVANCE: Rare and common genetic variation were associated with an increased risk of AF. The findings provide insights into the genetic underpinnings of AF and may aid in future genetic risk stratification.
引用
- Vad OB, Monfort LM, Paludan-Müller C, et al. Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk. JAMA Cardiol. 2024. PMID: 38922602. doi:10.1001/jamacardio.2024.1528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。